Intellia Therapeutics, Inc. · NASDAQ:NTLA
Dube Michael P sold 2,641 Intellia Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Dube Michael P (VP, Chief Accounting Officer) sold 2,641 Intellia Therapeutics, Inc. shares at US$16.78 for US$44,316, leaving 66,886 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 2,641 shares
- Price
- US$16.78
- Value
- US$44,316
- Holding after
- 66,886 shares
- Trading plan
- No
- Role
- VP, Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Sale | 2,641 | US$16.78 | 66,886 | Direct |
Source
Related
- Intellia Therapeutics, Inc.
- Dube Michael P
- Intellia Therapeutics, Inc. shareholders
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026
- Form 4 · Verwiel Frank · Jun 10, 2026